<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04195906</url>
  </required_header>
  <id_info>
    <org_study_id>SNFCT2017-06</org_study_id>
    <nct_id>NCT04195906</nct_id>
  </id_info>
  <brief_title>Phase 3 Study of SNF472 for Calciphylaxis</brief_title>
  <acronym>Calciphyx</acronym>
  <official_title>A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanifit Therapeutics S. A.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanifit Therapeutics S. A.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objectives are to assess the efficacy, safety, and tolerability of SNF472&#xD;
      compared to placebo when added to background care for the treatment of calciphylaxis (CUA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The formation and growth of calcified deposits in arterioles and other small blood vessels&#xD;
      appears to be fundamental to the development of CUA especially in end stage renal disease&#xD;
      patients. This phase 3 double-blind, randomized, placebo-controlled study is designed to&#xD;
      assess the effect of SNF472 when added to background care to improve wound healing, as&#xD;
      evaluated using Bates-Jensen Wound Assessment Tool (BWAT) scoring and pain as reported by the&#xD;
      subject using a VAS scale. The study consists of a double-blind, randomized, placebo&#xD;
      controlled period of 12 weeks followed by an open-label period of 12 weeks.. .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 12, 2020</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the BWAT-CUA score for the primary lesion</measure>
    <time_frame>Basline to week 12</time_frame>
    <description>The Bates Jensen Wound Assessment Tool (BWAT) CUA score ranges from a minimum score of 8 (best) to a maximum score of 40 (worst)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pain VAS score</measure>
    <time_frame>Baseline to Week 12</time_frame>
    <description>The Pain Visual Analog Scale (VAS) score ranges from a minimum score of 0 (no pain) to 100 (worst possible pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the Wound-QoL score</measure>
    <time_frame>Basline to Week 12</time_frame>
    <description>The Wound Quality of Life scale is a validated self-assessment tool that has been shown to be feasible for assessing health-related quality of life in patients with chronic wounds. Lower scores are associated with a better quality of life as reported by the patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the BWAT total score for the primary lesion</measure>
    <time_frame>Baseline to Week 12</time_frame>
    <description>The Bates Jensen Wound Assessment Tool (BWAT) score ranges from a minimum score of 9 (best) to a maximum score of 65 (worst) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitative wound image evaluation for the primary lesion</measure>
    <time_frame>Baseline to Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of change in opioid use as measured in morphine milligram equivalents (MME)</measure>
    <time_frame>Baseline to Week 12</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Calciphylaxis</condition>
  <condition>Calcific Uremic Arteriolopathy</condition>
  <arm_group>
    <arm_group_label>SNF472 (Double-Blind Period)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dose: 7 mg/kg SNF472 diluted in 100 mL physiological saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (Double-Blind Period)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo (saline) diluted in 100 mL physiological saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SNF472 (Open-Label)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dose: 7 mg/kg SNF472 diluted in 100 mL physiological saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Experimental: SNF472</intervention_name>
    <description>Administered 3 times weekly by intravenous infusion through the hemodialysis machine in conjunction with the subject's hemodialysis sessions for 12 weeks</description>
    <arm_group_label>SNF472 (Double-Blind Period)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Comparator: Placebo</intervention_name>
    <description>Administered 3 times weekly by intravenous infusion through the hemodialysis machine in conjunction with the subject's hemodialysis sessions fo 12 weeks</description>
    <arm_group_label>Placebo (Double-Blind Period)</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Experimatenl SNF472 (Open-label)</intervention_name>
    <description>Administered 3 times weekly by intravenous infusion through the hemodialysis machine in conjunction with the subject's hemodialysis sessions for 12 weeks</description>
    <arm_group_label>SNF472 (Open-Label)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female or male subjects, 18 years of age or older&#xD;
&#xD;
          -  Receiving maintenance HD in a clinical setting for at least 2 weeks prior to screening&#xD;
&#xD;
          -  Clinical diagnosis of CUA by the Investigator including ≥1 CUA lesion with ulceration&#xD;
             of the epithelial surface&#xD;
&#xD;
          -  CUA wound-related pain shown by a Pain VAS score ≥50 out of 100&#xD;
&#xD;
          -  Primary lesion that can be clearly photographed for the purpose of protocol-specified&#xD;
             wound healing assessments.&#xD;
&#xD;
          -  Willing and able to understand and sign the informed consent form and willing to&#xD;
             comply with all aspects of the protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of treatment with bisphosphonates within 3 months of baseline&#xD;
&#xD;
          -  Severely ill subjects without a reasonable expectation of survival for at least 6&#xD;
             months&#xD;
&#xD;
          -  Subjects with a scheduled parathyroidectomy during the study period&#xD;
&#xD;
          -  Expectation for kidney transplant within the next 6 months based on Investigator&#xD;
             assessment or identification of a known living donor&#xD;
&#xD;
          -  Pregnant or trying to become pregnant, currently breastfeeding, or of childbearing&#xD;
             potential (including perimenopausal women who have had a menstrual period within one&#xD;
             year) and not willing to comply with protocol required contraception criteria&#xD;
&#xD;
          -  Significant noncompliance with dialysis&#xD;
&#xD;
          -  History of active malignancy within the last year with the exception of localized&#xD;
             basal cell or squamous cell carcinoma&#xD;
&#xD;
          -  Clinically significant illness other than CUA within 30 days&#xD;
&#xD;
          -  Participation in an investigational study and receipt of an investigational drug or&#xD;
             investigational use of a licensed drug within 30 days prior to screening.&#xD;
&#xD;
          -  History or presence of active alcoholism or drug abuse as determined by the&#xD;
             Investigator within 6 months&#xD;
&#xD;
          -  Mental impairment, current significant psychiatric disease, or other conditions or&#xD;
             circumstances that would make the subject unlikely to complete the study or comply&#xD;
             with the study procedures.&#xD;
&#xD;
          -  Subjects whose CUA lesions exhibit significant improvement, in the opinion of the&#xD;
             Investigator, between the first and second screening visit&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alex Gold, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sanifit Therapeutics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen A Gillotti</last_name>
    <phone>+12033138185</phone>
    <email>InfoCUAtrial@sanifit.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurence H Keller, MD</last_name>
    <phone>+1 919 667-6914</phone>
    <email>InfoCUAtrial@sanifit.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>AKDHC Medical Research Services</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>Carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>California Institute of Renal Research</name>
      <address>
        <city>El Centro</city>
        <state>California</state>
        <zip>92243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>California Institute of Renal Research</name>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <zip>92027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Nephrology Group</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Kidney Disease Medical Group</name>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <zip>91204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Lynwood</city>
        <state>California</state>
        <zip>90260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>California Medical Research Associates</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Valley Renal Medical Group Research</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Apex Research of Riverside</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>Carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>North America Research Institute</name>
      <address>
        <city>San Dimas</city>
        <state>California</state>
        <zip>91773</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amicis Research Center</name>
      <address>
        <city>Vacaville</city>
        <state>California</state>
        <zip>95687</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Santa Fe Springs Dialysis Center</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Colorado Kidney Care</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Middlebury</city>
        <state>Connecticut</state>
        <zip>06762</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Boca Nephrology, PA</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Lauderdale Lakes</city>
        <state>Florida</state>
        <zip>33313</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Novel Outcomes Research</name>
      <address>
        <city>Spring Hill</city>
        <state>Florida</state>
        <zip>34667</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>Carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sagar Nigwekar, MD</last_name>
      <phone>617-726-7872</phone>
      <email>snigwekar@mgh.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Michigan Kidney Consultants</name>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <zip>48341</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Roseville</city>
        <state>Michigan</state>
        <zip>48066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Brookhaven</city>
        <state>Mississippi</state>
        <zip>39601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>Carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>22704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Piedmont Dialysis Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hypertension Nephrology Consultants, Inc</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kidney and Hypertension Center</name>
      <address>
        <city>Roseburg</city>
        <state>Oregon</state>
        <zip>89511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>Carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Chester</city>
        <state>Pennsylvania</state>
        <zip>19013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Knoxville Kidney Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37923</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn K Maloney</last_name>
      <email>Carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank C Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Lewisville</city>
        <state>Texas</state>
        <zip>75057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Clinical Advancement Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn K Maloney</last_name>
      <email>Carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington Nephrology Associates</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <zip>22304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Chesapeake</city>
        <state>Virginia</state>
        <zip>23320</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fresenius Kidney Care</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Maloney</last_name>
      <email>Carolyn.maloney@frenovarenalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Clinical Research</name>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Terschan</last_name>
      <email>frank.terschan@davita.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinques Universitaries de Bruxelles Hopital</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>infoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>infoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AZ Delta</name>
      <address>
        <city>Roeselare</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>infoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nephrologischen Zentrum Villingen-Schwenningen</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <state>Baden Wuerttemberg</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charite Universitaetsmedizin Berlin - Campus Charite Mitte</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Deutschland AG</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>infoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Dializ Fresenius, Ośrodek Dializ nr 10 w Bydgoszczy 85-826</name>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Violeta S Kanova</last_name>
      <email>vkanova@augustresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Dializ Fresenius, Ośrodek Dializ nr 18 w Krakowie..</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Violeta S Kanova</last_name>
      <email>vkanova@augustresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DaVita Sp. z o.o., Stacja Dializ w Miechowie</name>
      <address>
        <city>Miechów</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Violeta S Kanova</last_name>
      <email>vkanova@augustresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Dializ Fresenius Ośrodek Dializ nr 32 w Radomiu 26-617 .</name>
      <address>
        <city>Radom</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Violeta S Kanova</last_name>
      <email>vkanova@augustresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny nr 1 im. N. Barlickiego w Lodzi Stacja Dializ,</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Violeta S Kanova</last_name>
      <email>vkanova@augustresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundacio Puigvert</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Barcelona Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia</name>
      <address>
        <city>Córdoba</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Devon and Exeter Hospital (Wonford)</name>
      <address>
        <city>Exeter</city>
        <state>Devon</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Salford Royal NHS Foundation Trust</name>
      <address>
        <city>Salford</city>
        <state>Greater Manchester</state>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vascular Research Group</last_name>
      <phone>+441612061359</phone>
      <email>Vascular.Research@srft.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leicester General Hospital</name>
      <address>
        <city>Leicester</city>
        <state>Leicestershire</state>
        <zip>le5 4pw</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth University Hospital Campus</name>
      <address>
        <city>Glasgow</city>
        <state>Strathclyde</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>InfoCUAtrial@sanifit.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE59RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Ford, MD</last_name>
      <email>martinford2@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Abegail Hernandez Pena</last_name>
      <email>abby.pena@nhs.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>December 10, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2019</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Calciphylaxis</keyword>
  <keyword>Calcific Uremic Arteriolopathy</keyword>
  <keyword>Wound</keyword>
  <keyword>ESRD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calciphylaxis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

